|
|
| Hepatitis B Virus DNA, Ultra Sensitive Quantitative PCR | ||
| Order Code: HBVQNTUS
Order Form: A-1a Miscellaneous Request or IPR Req |
Commercial "Mail-out" Laboratory 6240 RCP 356-3527 |
|
Specimen |
Serum | ||
Collection Medium: |
| ||
Alternate Collection Media: |
Lavender top tube (EDTA), Pink top tube (EDTA sprayed) | ||
Minimum: |
Prefer 2 ml serum; absolute minimum 0.5 ml serum | ||
Rejection Criteria: |
Heparinized specimens. | ||
Analytic Time: |
4 days | ||
Reference Range: |
Less than 1.6 HBV DNA log IU/mL Less than 40 HBV DNA IU/mL | ||
Comments: |
Interpretive Date: ARUP Laboratories has determined that HBV DNA by TaqMan has an analytic specificity of greater than 99%. Rarely (less than 1%), a patient negative for HBV may test positive on this assay. Results in those cases are usually in the range of 40-600 IU/mL. A result of less than 40 HBV IU/mL does not rule out the presence of PCR inhibitors in the patient specimen or hepatitis B virus DNA concentrations below the limit of detection by the assay. Care should be taken when interpreting any single HBV DNA determination. Assay methodology is Real-Time PCR using Roche COBAS TaqMan HBV Analyte Specific Reagent. This is a nucleic acid amplification test for the quantitation of hepatitis B virus DNA in human serum or plasma. The analytical measurement range of this assay is 1.6 to 8.3 HBV DNA log IU/mL (40 to 200,000,000 IU/mL). 1 IU/mL of HBV DNA is approximately 5 copies/mL. 1 IU/mL of HBV DNA is approximately 0.000018 pg/mL. The International Unit (IU) is the assigned unit designation of the First International Standard for HBV DNA assays by the WHO Expert Committee on Biological Standardization (ECBS) and was assigned a titer of 1,000,000 IU/mL. The WHO HBV International Standard is a genotype A subtype adw2 isolate. This test is performed pursuant to an agreement with Roche Molecular Systems, Inc. This assay should not be used for blood donor screening, associated re-entry protocols, or for screening Human Cell, Tissues and Cellular Tissue-Based Products (HCT/P). | ||
Test Limitations: |
The inherent variation in any assay at low levels of HBV DNA requires cautious interpretation of values obtained at or near the limit of detection. | ||
Methodology: |
Real-Time Polymerase Chain Reaction | ||
CPT Code: |
87517 |
Updated: 09/10/2007
Note: The information contained in this handbook is for use by personnel of University of Iowa Health Care. No other use is implied or intended.